These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17401722)

  • 1. In vivo Schild regression analyses using nonselective 5-HT2C receptor antagonists in a rat operant behavioral assay.
    Walker EA; Brown EK; Sterious SN
    Psychopharmacology (Berl); 2007 Aug; 193(2):187-97. PubMed ID: 17401722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice.
    Walker EA; Kohut SJ; Hass RW; Brown EK; Prabandham A; Lefever T
    Neuropharmacology; 2005 Dec; 49(8):1210-9. PubMed ID: 16165167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.
    Farrell M; Rosenzweig-Lipson S; Walker E
    Psychopharmacology (Berl); 2010 Aug; 211(2):149-59. PubMed ID: 20526585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure.
    Walker EA; Foley JJ
    Behav Pharmacol; 2010 Mar; 21(2):83-9. PubMed ID: 20177374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior.
    Pentkowski NS; Duke FD; Weber SM; Pockros LA; Teer AP; Hamilton EC; Thiel KJ; Neisewander JL
    Neuropsychopharmacology; 2010 Sep; 35(10):2037-48. PubMed ID: 20520599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
    Yamada J; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):153-7. PubMed ID: 11011047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A; Girardon S; Millan MJ
    Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific.
    Boulougouris V; Robbins TW
    J Neurosci; 2010 Jan; 30(3):930-8. PubMed ID: 20089901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-hydroxytryptamine 2C receptor agonist MK212 and 2A receptor antagonist MDL100907 on maternal behavior in postpartum female rats.
    Chen W; Zhang Q; Su W; Zhang H; Yang Y; Qiao J; Sui N; Li M
    Pharmacol Biochem Behav; 2014 Feb; 117():25-33. PubMed ID: 24321440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds.
    Prinssen EP; Koek W; Kleven MS
    Eur J Pharmacol; 2000 Jan; 388(1):57-67. PubMed ID: 10657547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of 5-hydroxytryptamine-induced contraction in the chicken gastrointestinal tract.
    Kitazawa T; Ukai H; Komori S; Taneike T
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):157-68. PubMed ID: 16553644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
    McCreary AC; Filip M; Cunningham KA
    Behav Neurosci; 2003 Apr; 117(2):212-21. PubMed ID: 12708517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.
    Vickers SP; Easton N; Malcolm CS; Allen NH; Porter RH; Bickerdike MJ; Kennett GA
    Pharmacol Biochem Behav; 2001; 69(3-4):643-52. PubMed ID: 11509227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.